Compare SRTA & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SRTA | KIO |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | 601 | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.4M | 458.2M |
| IPO Year | N/A | 2011 |
| Metric | SRTA | KIO |
|---|---|---|
| Price | $6.23 | $11.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.81 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 167.2K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.27 | N/A |
| Revenue Next Year | $8.52 | N/A |
| P/E Ratio | $9.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.85 | $10.65 |
| 52 Week High | $6.50 | $12.83 |
| Indicator | SRTA | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 54.62 |
| Support Level | $4.08 | $10.66 |
| Resistance Level | N/A | $11.44 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 78.62 | 73.59 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.